LEWIS S BLEVINS

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SAN FRANCISCO, CA NPI 1295822393

General Payments — all program years on this page

$152,677.08

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 122
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $12,824.93 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
RECORDATI_RARE_DISEASES_INC. $9,867.638
Corcept Therapeutics $2,750.102
Xeris Pharmaceuticals, Inc. $157.203
Novo Nordisk AS $50.001

By program year

Program yearAmountRecords
2018 $8,096.875
2019 $16,139.8318
2020 $21,501.1723
2021 $41,437.5021
2022 $26,412.3314
2023 $26,264.4527
2024 $12,824.9314

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096889390 Novo Nordisk Inc $50.00 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117767624 Corcept Therapeutics $70.10 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117767712 Corcept Therapeutics $2,680.00 08/22/2024 Honoraria Undisputed 01/23/2026 View at CMS
1139161424 RECORDATI_RARE_DISEASES_INC. $1,200.00 02/27/2024 Honoraria Undisputed 01/23/2026 View at CMS
1139161426 RECORDATI_RARE_DISEASES_INC. $1,200.00 02/29/2024 Honoraria Undisputed 01/23/2026 View at CMS
1139161428 RECORDATI_RARE_DISEASES_INC. $1,200.00 02/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1139161430 RECORDATI_RARE_DISEASES_INC. $1,200.00 02/29/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1139161432 RECORDATI_RARE_DISEASES_INC. $155.13 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139161434 RECORDATI_RARE_DISEASES_INC. $1,200.00 05/23/2024 Honoraria Undisputed 01/23/2026 View at CMS
1139161436 RECORDATI_RARE_DISEASES_INC. $2,700.00 08/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1139161438 RECORDATI_RARE_DISEASES_INC. $1,012.50 08/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1144602761 Xeris Pharmaceuticals, Inc. $21.54 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144602763 Xeris Pharmaceuticals, Inc. $25.17 05/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144602765 Xeris Pharmaceuticals, Inc. $110.49 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.